ArticleCell death & disease2025
Downregulation of Engulfment and cell motility 1 (Elmo1) induces quiescence and resistance to poly(I:C)-induced apoptosis in endothelial cells.
Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Increased Urinary Albumin Excretion But Less Damaged Renal Tubular Structures in Mice with Genetically DecreasedInnovation discovery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Severe viral infections can cause cell death as a protective mechanism to eliminate defective cells and limit further viral propagation. However, the precise mechanism underlying the decision between cell survival and death remains unclear. Here, we demonstrate that Engulfment and Cell Motility 1 (ELMO1), an intracellular protein that facilitates cytoskeleton rearrangement through activation of Rac family small GTPase 1 (RAC1), is involved in the Toll-like receptor 3 (TLR3)-induced apoptosis in human umbilical vein endothelial cells. RNA sequencing of cells treated with ELMO1-targeting siRNA (siELMO1) revealed that knockdown of ELMO1 increased the transcripts of extracellular matrix genes including COL5A1 and decreased the expression of cell cycle and DNA replication-related genes such as CCND1 and CDK1. These siELMO1 treated cells also showed G1/S cell cycle arrest. When stimulated with polyinosinic-polycytidylic acid (poly(I:C)), a TLR3 agonist, inflammatory cytokines and chemokines such as CXCL8 and IL6 robustly increased in Mock-treated cells, while siNT (non-targeting) cells underwent massive cell death and showed reduced inflammatory responses, reflecting apoptosis-inducing effects of sequential TLR3 activation by siRNA and poly(I:C). Strikingly, siELMO1 cells were resistant to the cell death, and restored inflammatory cytokine responses to the same level as Mock-treated cells. Mechanistically, apoptosis in siNT increased through the activation of caspase-8, whereas downregulation of ELMO1 inhibited the cleavage of caspase-8. These results indicate that ELMO1 is involved in the regulation between survival or death in endothelial cells through the regulation of caspase-8 activity downstream of TLR3, suggesting the importance of the ELMO1 in cell proliferation as well as susceptibility to poly(I:C)-induced apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.